🔥🐔 BizChicken 🐔🔥
Companies Similar to Cytokinetics, Incorporated
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CytomX Therapeutics, Inc.
Probody technology platform
Cytom X Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops antibody therapeutics based on its Probody technology platform for treating cancer. Its product candidates include CX-2009, CX-2029, BMS-986249, BMS-986288, CX-2043, and CX-904, targeting various cancers and currently in clinical trials.
Symbol: CTMX
Recent Price: $1.02
Industry: Biotechnology
CEO: Dr. Sean A. McCarthy DPHIL
Sector: Healthcare
Employees: 120
Address: 151 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 515 3185
Last updated: 2024-12-31
Enliven Therapeutics, Inc.
small molecule kinase inhibitors
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule inhibitors for cancer treatment, including key products ELVN-001 and ELVN-002 under clinical trials.
About | About | Directors | About | Contact | Contact | Careers | Careers | Careers | Jobs | Careers | About | Vision/Values
Symbol: ELVN
Recent Price: $22.39
Industry: Biotechnology
CEO: Mr. Samuel S. Kintz M.B.A.
Sector: Healthcare
Employees: 52
Address: 6200 Lookout Road, Boulder, CO 80301
Phone: 720 647 8519
Leadership
- Sam Kintz, Co-founder, Chief Executive Officer, and Member of the Board of Directors
- Joe Lyssikatos, Co-founder, Chief Scientific Officer
- Anish Patel, Co-founder and Chief Operating Officer
- Helen Collins, Chief Medical Officer
- Ben Hohl, Chief Financial Officer and Head of Corporate Development
- Galya Blachman, Chief Legal Officer and Head of Business Development
- Rich A. Heyman, Chairman of the Board of Directors
- Rishi Gupta, Member of the Board of Directors
- Andy Phillips, Member of the Board of Directors
- Mika Kakefuda Derynck, Member of the Board of Directors
- Jake Bauer, Member of the Board of Directors
- Rahul Ballal, Member of the Board of Directors
- Lori Kunkel, Member of the Board of Directors
- Brian Druker, Scientific Advisor
- Kevin Koch, Scientific Advisor
Last updated: 2024-12-31
AnaptysBio, Inc.
Imsidolimab, Rosnilimab, ANB032
Anaptys Bio, Inc. is a clinical stage biotechnology company focused on developing therapeutic product candidates for inflammation and immuno-oncology indications. Their products target dermatological inflammatory diseases and other human inflammatory conditions.
Symbol: ANAB
Recent Price: $13.22
Industry: Biotechnology
CEO: Mr. Daniel R. Faga
Sector: Healthcare
Employees: 117
Address: 10770 Wateridge Circle, San Diego, CA 92121-5801
Phone: 858 362 6295
Last updated: 2024-12-31
Cyclerion Therapeutics, Inc.
CY6463
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious CNS diseases, with products like CY6463 for mitochondrial encephalomyopathy and Alzheimer's disease.
Symbol: CYCN
Recent Price: $3.45
Industry: Biotechnology
CEO: Dr. Regina Graul Ph.D.
Sector: Healthcare
Employees: 1
Address: 245 First Street, Cambridge, MA 02142
Phone: 857 327 8778
Last updated: 2024-12-31
Cytokinetics, Incorporated
muscle activators and inhibitors
Cytokinetics, Incorporated is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors to treat debilitating diseases.
About | About | Our Story | About | About | Our Story | Contact | Contact | About | Careers | Culture | Careers | DEI | Careers | Careers | Careers | About | About | About | About | About | News | About | News | Events | About | About | About | About | ESG | About | Contact | About | About | Vision/Values | Vision/Values | Leadership | Vision/Values | Vision/Values | Vision/Values | Vision/Values | Vision/Values | Vision/Values | About | About | About | About | About | Careers | Culture | Careers | Careers | DEI | Careers | Culture | Careers | Careers | Careers | About
Symbol: CYTK
Recent Price: $47.15
Industry: Biotechnology
CEO: Mr. Robert I. Blum
Sector: Healthcare
Employees: 423
Address: 350 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 624 3000
Last updated: 2024-12-31
Kiromic BioPharma, Inc.
ALEXIS-ISO-1, ALEXIS-PRO-1
Kiromic Bio Pharma, Inc. is an artificial intelligence-driven allogeneic cell therapy company that develops multi-indication T cell therapies, leveraging the Gamma Delta T cell to target solid tumors. Key products include ALEXIS-ISO-1 and ALEXIS-PRO-1.
Symbol: KRBP
Recent Price: $0.93
Industry: Biotechnology
CEO: Mr. Pietro Bersani CPA, J.D.
Sector: Healthcare
Employees: 35
Address: 7707 Fannin, Houston, TX 77054
Phone: 832 968 4888
Leadership
- Pietro Bersani, CPA, Director
- Leonardo Mirandola, PhD, Chief Scientific Officer/Interim COO
- Scott Dahlbeck, MD, PharmD, Chief of Staff
- Brian Hungerford, Chief Financial Officer
- Michael Nagel, Chairperson
- Michael Catlin, Independent Director
- Pam Misajon, Independent Director
Last updated: 2024-12-31
Inhibrx Biosciences, Inc.
Therapeutic Candidates (INBRX-109, INBRX-106)
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.
Symbol: INBX
Recent Price: $15.14
Industry: Biotechnology
CEO: Mr. Mark Paul Lappe
Sector: Healthcare
Employees: 166
Address: 11025 North Torrey Pines Road, La Jolla, CA 92037
Phone: 858-795-4220
Last updated: 2024-12-31
PharmaCyte Biotech, Inc.
Cell-in-a-Box
Pharma Cyte Biotech, Inc. is a biotechnology company focused on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites. Their therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology, used for treating various cancers and diabetes.
About | Management | Directors | ESG | About | Directors | Contact | ESG | About | About | About | About
Symbol: PMCB
Recent Price: $1.55
Industry: Biotechnology
CEO: Mr. Joshua N. Silverman
Sector: Healthcare
Employees: 2
Address: 3960 Howard Hughes Parkway, Las Vegas, NV 89169
Phone: 917 595 2850
Leadership
- Joshua N. Silverman, Independent Director
- Dr. Michael M. Abecassis, Independent Director
- Robert Weinstein, Director
- Wayne R. Walker, Director
- Jonathan L. Schechter, Independent Director
- Dr. Abecassis, Director
- Kenneth L. Waggoner, Independent Director
- Daniel C. Farb, Independent Director
- Daniel C. Allen, Independent Director
- Jack E. Stover, Independent Director
Last updated: 2024-12-31
BeiGene, Ltd.
BRUKINSA, Tislelizumab, REVLIMID, VIDAZA, XGEVA, BLINCYTO, KYPROLIS, SYLVANT, QARZIBA, Pamiparib, Pobevcy
Bei Gene, Ltd. is a biotechnology company focused on discovering, developing, manufacturing, and commercializing a wide range of medicines globally, specializing in oncology treatments and clinical stage drug candidates.
About | About | Vision/Values | About | About | Culture | DEI | Culture | Leadership | About | Contact | Careers | Careers | Careers | Careers | About | About | About | About | About | Jobs | About | About | About
Symbol: BGNE
Recent Price: $183.81
Industry: Biotechnology
CEO: Mr. John V. Oyler
Sector: Healthcare
Employees: 10000
Address: 55 Cambridge Parkway, Cambridge, MA 02142
Phone: 781-801-1800
Leadership
- John V. Oyler, Co-Founder, Chairman and CEO
- Xiaodong Wang, Ph.D., Co-Founder, Chairman of Scientific Advisory Board
- Olivier Brandicourt, M.D., Director
- Margaret Dugan, M.D., Director
- Donald W. Glazer, Director
- Michael Goller, Director
- Anthony Hooper, Director
- Ranjeev Krishana, Director
- Michael Nuoqing Yi, Director
- Alessandro Riva, M.D., Director
- Corsee Sanders, Ph.D., Director
- Shalini Sharp, Director
- Steven Young, Ph.D., Acting Head of Medicinal Chemistry
- Ron Levy, M.D., Scientific Advisory Board
- Neal Rosen, M.D., Ph.D., Scientific Advisory Board
- Charles Sawyers, M.D., Scientific Advisory Board
- David Schenkein, M.D., Scientific Advisory Board
- Melika Davis, SVP & Global Head, Clinical Operations
- Clare Fisher, SVP, Business Development, Licensing, and M&A (ex-China)
- Tony Guo, Ph.D., SVP, Global Statistics & Data Science
- Dany Habr, M.D., Head of Medical Affairs, North America & International Markets
- Graham Hardiman, Global Head of HR
- Shreya Devendra Jani, SVP, Corporate Affairs
- Jaspreet Jaggi, M.D., Ph.D., SVP and Head, Clinical Portfolio Strategy
- Yang Ji, Chief Compliance Officer
- Mark Lanasa, M.D., Ph.D., SVP, Chief Medical Officer, Solid Tumors
- Chan Lee, General Counsel
- Kyu-Sung Lee, Ph.D., SVP, Global Head of Technical Operations and Manufacturing
- Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer
- Kyoung Lim, VP of Supply Chain
- Han Ma, M.D., Ph.D., Chief Safety Officer and SVP, Global Patient Safety
- Mehrdad Mobasher, M.D., M.P.H., Chief Medical Officer, Hematology
- Richard O’Keeffe, Head of Global Quality
- Jurij Petrin, M.D., Head of New Market Development
- Yan Qi, Ph.D., SVP, Head of Public Affairs
- Hongyu Qian, SVP, Medical Affairs
- Jason Radford, SVP, Strategy & Corporate Development
- Anand Reddi, VP, Global Strategic Initiatives and Corporate Operations, Chief of Staff to the CEO
- Adam Roach, VP and Head of Asia Pacific
- Aaron Rosenberg, Chief Financial Officer
- Michael Schoen, Strategic Advisor and Special Assistant to the CEO
- Matt Shaulis, General Manager of North America
- Lai Wang, Ph.D., Global Head of R&D
- Zhiwei Wang, Ph.D., SVP, Research Head of Chemistry
- Beth Wensley, SVP, Head of Portfolio and Program Management
- Kimberly Wolf, SVP, Global Commercial Strategy & Operations
- Xiaobin Wu, Ph.D., President, Chief Operating Officer
- Eva Yin, Chief Commercial Officer, Greater China
Last updated: 2024-12-31
Celularity Inc.
CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.
About | Leadership | Directors | About | About | About | About | Directors | Careers | About | About | About | About | About | About
Symbol: CELU
Recent Price: $2.05
Industry: Biotechnology
CEO: Dr. Robert Joseph Hariri M.D., Ph.D.
Sector: Healthcare
Employees: 120
Address: 170 Park Avenue, Florham Park, NJ 07932
Phone: 908 768 2170
Leadership
- Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
- David Beers, CFA, Chief Financial Officer
- Stephen Brigido, DPM, President, Degenerative Diseases
- John Haines, Global Manager and Chief Administrative Officer
- K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
- John Colerangle, DVM, Ph.D., Regulatory Affairs
- Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
- Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
- Carmine Palummo, Corporate Operations
- Tim Wilk, Technical Operations
- Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
- Peter Diamandis, M.D., Director
- Dean Kehler, Director
- Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
- Diane Parks, Director
Last updated: 2024-12-31
Inhibikase Therapeutics, Inc.
Ik T-148009
Inhibikase Therapeutics, Inc. is a clinical stage pharmaceutical company focused on developing therapeutics for Parkinson's Disease and related disorders. Their product pipeline includes treatments for neurological and cancer-related conditions.
About | Leadership | Directors | About | About | About | Contact | Careers | About | About | About | About
Symbol: IKT
Recent Price: $3.24
Industry: Biotechnology
CEO: Dr. Milton H. Werner Ph.D.
Sector: Healthcare
Employees: 8
Address: 3350 Riverwood Parkway SE, Atlanta, GA 30339
Phone: 678 392 3419
Leadership
- Milton H. Werner, Ph.D., President and CEO
- C. Warren Olanow MD, FRCPC, FRCP (Hon.), Medical Consultant and CEO of Clintrex Research Corporation
- Garth Lees-Rolfe, CPA, Chief Financial Officer
- Dan Williams, Controller
- Terence Kelly, Ph.D., Medicinal Chemistry Consultant
- Surendra Singh, Ph.D., Chemistry and Manufacturing Controls
- Merrill M. Kraines, Partner, McDermott, Will & Emery, Outside General Counsel
- Roberto Bellini, Managing Partner at BSQUARED Capital
- Dennis Berman, Serial Entrepreneur
- David Canner, Ph.D., Partner at Soleus Capital
- Roy Freeman, M.D., Professor of Neurology at the Harvard Medical School, Director of the Center for Autonomic and Peripheral Nerve Disorders, Beth Israel Deaconess Medical Center
- Arvind Kush, Chief Financial Officer and Chief Business Officer of Candid Therapeutics
- Amit Munshi, Chief Executive Officer of Orna Therapeutics
Last updated: 2024-12-31
Incyte Corporation
JAKAFI, PEMAZYRE, ICLUSIG
Incyte Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics, with products like JAKAFI, PEMAZYRE, and ICLUSIG for various cancer treatments.
About | Leadership | Contact | Contact | Locations | Contact | Contact | Culture | Jobs | Culture | DEI | News | Events | About | About | Careers | Jobs | Careers | Careers | DEI | Culture | Careers | Culture | DEI | Careers | Locations | Careers | About | About | About | About | About | Careers | About | About | Culture
Symbol: INCY
Recent Price: $68.42
Industry: Biotechnology
CEO: Mr. Herve Hoppenot
Sector: Healthcare
Employees: 2524
Address: 1801 Augustine Cut-Off, Wilmington, DE 19803
Phone: 302 498 6700
Leadership
- Hervé Hoppenot, Chairman and Chief Executive Officer
- Paula J. Swain, Executive Vice President, Human Resources
- Pablo J. Cagnoni, M.D., President, Head of Research and Development
- Steven H. Stein, M.D., Executive Vice President and Chief Medical Officer
- Sheila A. Denton, J.D., Executive Vice President and General Counsel
- Christiana Stamoulis, MBA, Executive Vice President and Chief Financial Officer
- Barry P. Flannelly, PharmD, MBA, Executive Vice President and General Manager, North America
- Denise Brashear, Vice President, Head of Global Communications
- Vijay Iyengar, M.D., Executive Vice President, Global Medical Affairs, Product, and Partnership Strategy (GMAP2S)
- Lee Heeson, Executive Vice President, Head of Incyte International
- Michael Morrissey, Executive Vice President and Head of Global Technical Operations
- Matteo Trotta, MBA, Executive Vice President, General Manager, U.S. Dermatology
- Xiaozhao Wang, Ph.D., Associate Vice President, Head of Medicinal Chemistry
- Julian C. Baker, Managing Partner
- Jean-Jacques Bienaime, Former Chief Executive Officer
- Otis Brawley, M.D., Bloomberg Distinguished Professor of Oncology and Epidemiology
- Paul J. Clancy, Former Executive Vice President and Senior Advisor
- Jacqualyn A. Fouse, Ph.D., Former Chief Executive Officer
- Edmund P. Harrigan, M.D., Former Senior Vice President of Worldwide Safety and Regulatory
- Katherine High, M.D., Former President and Head of Research and Development
- Susanne Schaffert, Ph.D., Former President
Last updated: 2024-12-31
Kala Pharmaceuticals, Inc.
KPI-012, EYSUVIS, INVELTYS
Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for eye diseases using proprietary mucus penetrating particles technology.
Contact | Careers | Jobs | Careers | Careers | Careers | Careers | Leadership | Careers | Contact | Careers | Careers | Careers | About
Symbol: KALA
Recent Price: $6.87
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Mark T. Iwicki
Sector: Healthcare
Employees: 43
Address: 1167 Massachusetts Avenue, Arlington, MA 02476
Phone: 781 996 5252
Last updated: 2024-12-31
Kymera Therapeutics, Inc.
novel small molecule therapeutics
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system.
About | About | Leadership | Foundation | Contact | Culture | About | About | Leadership | Foundation | About | About | About | Culture | Culture | Culture | Culture | About | About
Symbol: KYMR
Recent Price: $39.32
Industry: Biotechnology
CEO: Dr. Nello Mainolfi M.D., Ph.D.
Sector: Healthcare
Employees: 184
Address: 200 Arsenal Yards Boulevard, Watertown, MA 02472
Phone: 857 285 5300
Leadership
- Nello Mainolfi, Ph.D., Founder, President & CEO
- Jeremy Chadwick, Ph.D., Chief Operating Officer
- Ellen Chiniara, JD, Chief Legal Officer and Corporate Secretary
- Jared Gollob, MD, Chief Medical Officer
- Bruce Jacobs, CFA, MBA, Chief Financial Officer
- Karen Weisbach, Head of People and Culture
- Juliet Williams, Ph.D., Head of Research
- Bruce Booth, DPhil, Chairman and Co-Founder
- Felix J. Baker, PhD, Lead Independent Director
- Jeff Albers, JD, MBA,
- Pamela Esposito, PhD,
- Gorjan Hrustanovic, PhD,
- John Maraganore, PhD,
- Leigh Morgan,
- Victor Sandor, MDCM,
- Elena Ridloff, CFA,
Last updated: 2024-12-31
Synaptogenix, Inc.
Bryostatin-1
Synaptogenix, Inc. is a biopharmaceutical company focused on developing drug candidates for neurodegenerative diseases, including Alzheimer's disease, using Bryostatin-1.
Symbol: SNPX
Recent Price: $3.37
Industry: Biotechnology
CEO: Dr. Alan J. Tuchman M.D., MBA(FAAN)
Sector: Healthcare
Employees: 5
Address: 1185 Avenue of the Americas, New York, NY 10036
Phone: 973 242 0005
Last updated: 2024-12-31
Synlogic, Inc.
Synthetic Biotic Medicines
Synlogic, Inc. is a clinical-stage biopharmaceutical company focused on the development of synthetic biotic medicines to treat metabolic and immunological diseases. The company's pipeline includes drug candidates for conditions such as phenylketonuria, homocystinuria, enteric hyperoxaluria, and solid tumors and lymphoma.
Symbol: SYBX
Recent Price: $1.40
Industry: Biotechnology
CEO: Mr. Antoine Awad
Sector: Healthcare
Employees: 6
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 617 401 9975
Last updated: 2024-12-31
Xencor, Inc.
Monoclonal Antibody and Cytokine Therapeutics
Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.
About | ESG | Contact | Careers | Careers | About | Events | About | About | About | Contact | Management | About | Directors | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers
Symbol: XNCR
Recent Price: $23.71
Industry: Biotechnology
CEO: Dr. Bassil I. Dahiyat Ph.D.
Sector: Healthcare
Employees: 280
Address: 111 West Lemon Avenue, Monrovia, CA 91016
Phone: 626 305 5900
Last updated: 2024-12-31
Nuvation Bio Inc.
NUV-422
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focusing on the development of therapeutic candidates for oncology, such as NUV-422, a small molecule inhibitor targeting cyclin-dependent kinases, among other innovative treatments.
Symbol: NUVB
Recent Price: $2.62
Industry: Biotechnology
CEO: Dr. David T. Hung M.D.
Sector: Healthcare
Employees: 51
Address: 1500 Broadway, New York, NY 10036
Phone: 332 208 6102
Last updated: 2024-12-31
Crinetics Pharmaceuticals, Inc.
Paltusotine
Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on discovering, developing, and commercializing therapeutics for rare endocrine diseases and related tumors. Their leading product candidate, Paltusotine, has completed phase III trials for acromegaly treatment.
About | About | About | Contact | Contact | About | About | Culture | Culture | Careers | Jobs | Benefits | Jobs | Careers | Careers | Careers | About | About | About | About | About | About | About | About | About | About | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Careers | Vision/Values | Careers | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Culture | Jobs | Careers | Culture | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About | Careers | Careers
Symbol: CRNX
Recent Price: $50.67
Industry: Biotechnology
CEO: Dr. R. Scott Struthers Ph.D.
Sector: Healthcare
Employees: 290
Address: Building No. 2, San Diego, CA 92121
Phone: 858 450 6464
Last updated: 2024-12-31
Immix Biopharma, Inc.
IMX-110, IMX-111, IMX-120
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.
Symbol: IMMX
Recent Price: $2.36
Industry: Biotechnology
CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Sector: Healthcare
Employees: 14
Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064
Phone: 310 651 8041
Last updated: 2024-12-31